Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06044740 · ClinicalTrials.gov registry record · Early Phase 1
Sevoflurane's Effect on Neurocognition Study
A Early Phase 1 study, sponsored by Keith M Vogt.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 42
- Enrollment target
NCT06044740 is a Early Phase 1 study that has completed, run by Keith M Vogt. The registered enrollment target is 42 participants.
The verdict
NCT06044740, a Early Phase 1 study, has completed, sponsored by Keith M Vogt.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of acute pain on long-term memory and conditioned physiologic responses in the presence and absence of low dose sevoflurane. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena. The study will occur over 2 visits and involves no long-term follow up.
Interventions
- DRUG Sevoflurane
- DEVICE Peripheral Nerve Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2024-01-17 |
| Est. Completion | 2026-01-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06044740
The ClinicalTrials.gov registry entry for NCT06044740 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Keith M Vogt, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sevoflurane is the first listed.
NCT06044740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06044740 about?
NCT06044740 is a clinical study titled "Sevoflurane's Effect on Neurocognition Study". The purpose of this study is to determine the effects of acute pain on long-term memory and conditioned physiologic responses in the presence and absence of low dose sevoflurane. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena. The study will o...
What is the current status of trial NCT06044740?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 42 participants. The study started on 2024-01-17. Estimated completion is 2026-01-30.
What interventions are being tested in trial NCT06044740?
The interventions under investigation include: Sevoflurane (DRUG), Peripheral Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT06044740?
This trial is sponsored by Keith M Vogt, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.